# Quark Venture

Quark Venture is a Venture Capital based in Vancouver, Canada.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Vancouver, Canada
- **Region:** North America
- **Address:** Vancouver, BC, Canada
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** www.quarkventure.com
- **LinkedIn:** https://www.linkedin.com/company/quarkventure

## Regulatory record

- **Reports private funds:** No

## About

Quark Venture is a venture capital firm based in Vancouver, Canada, focused on equity financing of biotechnology and health sciences companies. The firm has made 40 investments, including a Series D investment in Lyndra Therapeutics on June 07, 2023. Quark Venture has 8 portfolio exits, with V-Wave exiting on August 20, 2024.

## Sectors

- Digital Health
- Healthcare Services
- AI/ML

## People

- Karimah Es Sabar — Chief Executive Officer & Partner

## Questions

### Who runs investment decisions at Quark Venture?

Karimah Es Sabar leads the firm as CEO and Partner. She brings a blended background in pharmaceutical R&D, business development, and venture capital, including prior leadership roles at GlaxoSmithKline and life sciences investment platforms. Investment decisions are made by a small, science-heavy partnership team that evaluates deals through both clinical and commercial lenses, rather than by a large investment committee.

### Does Quark Venture participate in fund commitments or only direct deals?

Quark Venture primarily makes direct investments in early-stage biotech and health technology companies. The firm's public disclosures emphasize equity and convertible instrument positions in individual portfolio companies. There is no public evidence of a fund-of-funds allocation strategy; the GF Securities capital was structured to flow directly into operating companies.

### How is Quark Venture related to GF Securities?

GF Securities, a major Chinese investment bank and securities firm, committed $500 million to anchor Quark Venture's global health sciences strategy at the firm's 2015 launch. The relationship provides Quark Venture with its core capital base and a bridge to Chinese life sciences companies and markets. Quark Venture operates independently from Vancouver, with GF Securities as its foundational strategic limited partner.

### What is Quark Venture's known posture on co-investments alongside external investors?

Quark Venture regularly co-invests alongside other specialist biotech venture funds, particularly in cross-border rounds where its GF Securities relationship adds strategic value for portfolio companies seeking Asian market entry. The firm does not market itself as a co-investment vehicle for outside LPs; it acts as a lead or co-lead investor deploying its own committed capital.

## Related profiles

- [QuarkInvest](https://altss.com/profile/quarkinvest)
- [Quarry Capital Management](https://altss.com/profile/quarry-capital-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/quark-venture

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology